Profile:
Herbert J. Zeh III, MD, is chief of the Division of Gastrointestinal (GI) Surgical Oncology at UPMC CancerCenter, co-director of the UPMC Pancreatic Cancer Center, co-director of the UPCI GI Oncology Program at UPMC, and professor of surgery at the University of Pittsburgh School of Medicine. Dr. Zeh specializes in cancers and diseases of the stomach, liver, pancreas, and duodenum, and practices state-of-the-art robotic technology.
Board-certified in surgery, Dr. Zeh received a medical degree from the University of Pittsburgh School of Medicine. He completed post-graduate training in advanced GI surgery and surgical oncology at The Johns Hopkins Hospital in Baltimore, where he served as senior and chief resident, as well as the Society of Surgical Oncology fellow. Dr. Zeh served as a surgical oncology medical staff fellow at the National Cancer Institute - Surgery Branch in Bethesda, MD.
Dr. Zeh is a member of several professional organizations, including the Society of Surgical Oncology (SSO), American Society of Clinical Oncology (ASCO), the Society of University Surgeons (SUS), and the Pancreas Club. Dr. Zeh had authored over 70 peer reviewed articles and book chapters. He directs a translational research laboratory examining Damage Associated Molecular Pattern molecules (DAMP) in the setting of pancreatic cancer. In addition, Dr. Zeh is principle investigator on several Phase I and II clinical trials in pancreatic cancer. Dr. Zeh, together with his team at UPMC, has accumulated one of the world's largest experiences with robotic assisted pancreatic resections.
